| 000 | 06055cam a2200733Ma 4500 | ||
|---|---|---|---|
| 005 | 20250930135712.0 | ||
| 008 | 140627s2013 nyua foab 001 0 eng d | ||
| 020 |
_z9781606506004 (print) _cRM292.34 |
||
| 020 | _z9780791860113 (print) | ||
| 020 | _z0791860116 (print) | ||
| 039 | 9 |
_a201501061252 _bhayat _c201410271525 _djamil _c201410271524 _djamil _c201410201515 _datika _y06-27-2014 _zbinar |
|
| 040 |
_aNYMPP _beng _cNYMPP _dE7B _dOCLCF _dOCLCO _dJ2I _dUKM |
||
| 090 | _aQP801.P64K263 2013 3 | ||
| 090 |
_aQP801.P64 _bK263 2013 3 |
||
| 100 | 1 |
_aKapoor, Deepak N, _eauthor. |
|
| 245 | 1 | 0 |
_aBiocompatible nanomaterials for targeted and controlled delivery of biomacromolecules / _cDeepak N. Kapoor and Sanju Dhawan. |
| 260 |
_aNew York, N. Y. : _bASME , _c2013. |
||
| 300 |
_a1 online resource (47 p.) : _billustrations., digital file. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aelectronic _2isbdmedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 490 | 1 | _aBiomedical and nanomedical technologies | |
| 500 | _aTitle from PDF t.p. (viewed on May 29, 2013). | ||
| 504 | _aIncludes bibliographical references (p. 38-47) and index. | ||
| 505 | 0 | _a1. Nanomaterials: a brief introduction -- | |
| 505 | 8 | _a2. Tissue and blood-material interactions -- 2.1 Tissue response -- 2.2 Blood response -- 2.3 Cellular response -- | |
| 505 | 8 | _a3. Biocompatibility -- | |
| 505 | 8 | _a4. Biodegradation -- | |
| 505 | 8 | _a5. Biocompatible and biodegradable nanomaterials -- 5.1 Organic nanomaterials -- 5.1.1 Natural and modified natural nanomaterials -- 5.1.2 Synthetic polymeric nanomaterials -- 5.2 Stealth nanomaterials -- 5.3 Inorganic nanomaterials -- 5.3.1 Carbon nanotubes (CNTs) -- 5.3.2 Quantum dots (QDs) -- 5.3.3 End-capped mesoporous silica nanoparticles -- 5.4 Metal nanoparticles -- 5.4.1 Gold nanoparticles (Au-Nps) -- 5.4.2 Silver nanoparticles -- 5.5 Magnetic nanoparticles -- 5.6 Nanocomposites, nanofibres and nanowires -- 5.7 Hybrid nanomaterials -- 5.8 Virus-like nanocarriers -- 5.9 Multifunctional nanoparticles -- | |
| 505 | 8 | _a6. Biomacromolecules -- 6.1 Cell penetrating peptides in biomacromolecular delivery -- 6.2 Targeted biomacromolecular delivery -- | |
| 505 | 8 | _a7. Challenges in biomacromolecular delivery -- | |
| 505 | 8 | _a8. Preparation techniques of biocompatible nanostructures -- 8.1 Top-down techniques -- 8.1.1 Dispersion of preformed polymers -- 8.1.2 Polymerization methods -- 8.1.3 Ionic gelation method for hydrophilic polymers -- 8.1.4 Hybrid assemblies -- 8.2 Bottom-up techniques -- 8.3 Scalable methods -- | |
| 505 | 8 | _a9. Characterization and evaluation -- 9.1 Drug-polymer compatibility -- 9.2 Particle size and shape -- 9.3 Zeta potential -- 9.4 Drug release evaluation -- 9.5 Conformational stability -- 9.6 Biocompatibility studies -- 9.7 Pre-clinical evaluation -- | |
| 505 | 8 | _a10. Regulatory perspectives -- | |
| 505 | 8 | _a11. Industrial viability -- | |
| 505 | 8 | _a12. Conclusions -- References. | |
| 506 | _aRestricted to subscribers or individual electronic text purchasers. | ||
| 520 | 3 | _aNanomaterials are organic or inorganic entities employed for the construction of various nanostructured devices or systems with nanometric dimensions. These nanostructures may include nanoparticles, nanowires, nanotubes, nanocapsules, nanocomposites as well as nanoporous solids. Nanomaterials have gained immense recognition, particularly in biomacromolecular delivery, owing to their capability of controlling the release rate or targeting the therapeutic moieties at molecular, cellular and organ level. Additionally, the problems of conformational and degradation stability associated with biomacromolecules like peptides, proteins, and genes have been addressed successfully by employing these nanomaterials. The degradation products of these biocompatible nanomaterials are non-toxic, non-immunogenic and easily resorbable by the regular physiological processes. The present chapter endeavors to describe the role of nanomaterials in the design, fabrication and development of various nanostructured, biomacromolecular delivery systems and devices. The chapter presents a discussion on various physicochemical properties, preparation techniques and analytical tools for characterizing these systems. The mechanisms of cellular internalization of nanomaterial based targeted systems are also discussed. Taking lead from various successful case studies, the present chapter provides a bird's eye view on the current advances in the field of nanomaterial based biomacromolecular delivery. A brief overview pertaining to the regulatory requirements and commercialization of these systems is also included. Various challenges posed during the development, scale up and large-scale production is also discussed. In a nutshell, besides, providing the salient details about the formulation and applications of biocompatible nanomaterials, the chapter would act as a ready reference for drug delivery scientists, device fabrication engineers and medical researchers working in this area. | |
| 650 | 0 | _aMacromolecules. | |
| 650 | 0 |
_aNanostructured materials. _963530 |
|
| 650 | 0 | _aDrug delivery systems. | |
| 650 | 0 | _aNanomedicine. | |
| 650 | 2 |
_aNanostructures. _960468 |
|
| 650 | 2 | _aDrug Delivery Systems. | |
| 650 | 2 | _aNanomedicine. | |
| 653 | _ananomaterials. | ||
| 653 | _aengineering. | ||
| 653 | _aorganic. | ||
| 653 | _ainorganic entities. | ||
| 653 | _abiomacromolecular delivery. | ||
| 653 | _aregulatory requirements. | ||
| 653 | _acommercialization. | ||
| 653 | _abiocompatible. | ||
| 655 | 0 | _aElectronic books. | |
| 700 | 1 | _aDhawan, Sanju. | |
| 907 |
_a.b15938347 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQP801.P64K263 2013 3 |
||
| 914 | _avtls003563597 | ||
| 990 | _anab | ||
| 991 | _aFakulti Kejuruteraan dan Alam Bina | ||
| 998 |
_al _b2014-01-06 _cm _da _feng _gnyu _y0 _z.b15938347 |
||
| 999 |
_c573250 _d573250 |
||